Panlin Capital
  • 简体中文
  • English
  • Home
  • About Us
  • Portfolios
  • Partner Team
  • News
All
Panlin Build
Biotechnology
Data Intelligence
Others
12/26
2023
Panlin Capital Announces Second Closing for its Healthcare Venture Capital Fund; Has Raised a Total of RMB 1.5 Billion in the Last Two Years
Panlin News
07/25
2023
Panlin Capital's Chengdu Fund closed successfully, has invested in several technology projects.
Panlin News
09/19
2021
Panlin Capital Raises 1 Billion Yuan for its New Flagship Fund
Panlin News
07/29
2021
Genfleet Receives IND Approval for KRAS G12C Inhibitor
Panlin Family
07/23
2021
GenFleet Forms Strategic Partnership with Insilico and Biortus
Panlin Family
04/27
2021
GenFleet Starts First-in-human Phase I Trial of RIPK1 Inhibitor
Panlin Family
01/27
2021
GenFleet Therapeutics Completes Series B+ Financing
Panlin Family
11/06
2020
Apollomics, Inc. Closes $124 Million Series C Financing
Panlin Family
09/19
2019
Li Yuhui of Panlin Capital: Beyond the Comfort Zone—A “Sniper” in Constant Pursuit of Excellence
Panlin Insight
01/07
2019
Apollomics, Inc. (previously CBT Pharmaceuticals, Inc.) Raises $100 Million in Series B Financing
Panlin Family
  • Home
  • About Us
  • Portfolios
  • Partner Team
  • News

25th Floor, T1 Building, LJZ FINANCIAL HOLDINGS PLAZA 1788、1800 Century Avenue, Pudong, Shanghai, 200122

Tel: 021-51621800

  • BP Submission:master@panlincap.com
  • Investor relations: ir@panlincap.com
  • Resume Delivery: hr@panlincap.com
  • Public Relations: pr@panlincap.com

WeChat

© 2021 Panlin Capital. All Rights Reserved.